Literature DB >> 2191712

A comparison of local and systemic acyclovir in the management of herpetic disciform keratitis.

S M Porter1, A Patterson, P Kho.   

Abstract

Forty-three patients with active herpetic disciform keratitis were entered into an open study to compare the efficacy of oral acyclovir (400 mg) with acyclovir ophthalmic ointment (3%) to inhibit viral replication during treatment with 0.05% prednisolone eye drops. All patients, regardless of the mode of therapy, were treated five times a day until they were healed. The mean time to heal in the oral group was 25.9 days and in the topical group was 25.3 days. Resolution of lacrimation was significantly faster in the oral group (12.1 days versus 27.6 days). The patients on tablets also showed a greater improvement in visual acuity. No statistically significant differences were found between the two groups in the incidence of recurrences over a three-year post-treatment period. It is concluded that oral acyclovir treatment is an effective alternative to ophthalmic ointment in the management of herpetic disciform keratitis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2191712      PMCID: PMC1042099          DOI: 10.1136/bjo.74.5.283

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  8 in total

1.  Intraocular antiviral penetration.

Authors:  R H Poirier; J D Kingham; P de Miranda; M Annel
Journal:  Arch Ophthalmol       Date:  1982-12

2.  Comparative efficacy of antiherpes drugs against different strains of herpes simplex virus.

Authors:  E De Clercq; J Descamps; G Verhelst; R T Walker; A S Jones; P F Torrence; D Shugar
Journal:  J Infect Dis       Date:  1980-05       Impact factor: 5.226

3.  Growth inhibition by acycloguanosine of herpesviruses isolated from human infections.

Authors:  C S Crumpacker; L E Schnipper; J A Zaia; M J Levin
Journal:  Antimicrob Agents Chemother       Date:  1979-05       Impact factor: 5.191

4.  A randomised double-blind clinical trial of acyclovir (Zovirax) and adenine arabinoside in herpes simplex corneal ulceration.

Authors:  B J Young; A Patterson; T Ravenscroft
Journal:  Br J Ophthalmol       Date:  1982-06       Impact factor: 4.638

5.  Pharmacokinetics of oral acyclovir (Zovirax) in the eye.

Authors:  S O Hung; A Patterson; P J Rees
Journal:  Br J Ophthalmol       Date:  1984-03       Impact factor: 4.638

6.  A double-blind comparative trial of acyclovir and adenine arabinoside in combination with dilute betamethasone in the management of herpetic disciform keratitis.

Authors:  L M Collum; D M Grant
Journal:  Curr Eye Res       Date:  1987-01       Impact factor: 2.424

7.  Acyclovir treatment in stromal herpetic keratitis.

Authors:  J A Oosterhuis; R van Ganswijk; J Versteeg
Journal:  Doc Ophthalmol       Date:  1983-12-15       Impact factor: 2.379

8.  Acyclovir (Zovirax) in herpetic disciform keratitis.

Authors:  L M Collum; P Logan; T Ravenscroft
Journal:  Br J Ophthalmol       Date:  1983-02       Impact factor: 4.638

  8 in total
  7 in total

1.  Recurrence rate of herpetic uveitis in patients on long-term oral acyclovir.

Authors:  A Rodriguez; W J Power; R A Neves; C S Foster
Journal:  Doc Ophthalmol       Date:  1995       Impact factor: 2.379

2.  Risk factors for herpes simplex virus epithelial keratitis recurring during treatment of stromal keratitis or iridocyclitis. Herpetic Eye Disease Study Group.

Authors:  K R Wilhelmus; C R Dawson; B A Barron; P Bacchetti; L Gee; D B Jones; H E Kaufman; J Sugar; R A Hyndiuk; P R Laibson; R D Stulting; P A Asbell
Journal:  Br J Ophthalmol       Date:  1996-11       Impact factor: 4.638

Review 3.  Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  A J Wagstaff; D Faulds; K L Goa
Journal:  Drugs       Date:  1994-01       Impact factor: 9.546

Review 4.  Herpes keratitis.

Authors:  A M Rowe; A J St Leger; S Jeon; D K Dhaliwal; J E Knickelbein; R L Hendricks
Journal:  Prog Retin Eye Res       Date:  2012-08-27       Impact factor: 21.198

5.  A stepping stone in treating dendritic keratitis.

Authors:  Hosam Sheha; Sean Tighe; Anny M S Cheng; Scheffer C G Tseng
Journal:  Am J Ophthalmol Case Rep       Date:  2017-06-06

Review 6.  MicroRNAs in Ocular Infection.

Authors:  Shunbin Xu; Linda D Hazlett
Journal:  Microorganisms       Date:  2019-09-17

Review 7.  Adoption of Innovation in Herpes Simplex Virus Keratitis.

Authors:  James Chodosh; Lawson Ung
Journal:  Cornea       Date:  2020-11       Impact factor: 3.152

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.